A study on patients with Alzheimer’s disease suggested that a carboxypeptidase E/neurotrophic factor-α1 gene mutation in humans leads to impaired memory acquisition and depressive-like symptoms in transgenic mice (41). This evidence concerns the gene CPE and early-onset autosomal dominant Alzheimer disease.